Health Condition 1: N768- Other specified inflammation of vagina and vulva
Conditions
Interventions
Intervention1: Guduchidantyadi Vati: Group 1
Dose-2 vati (500mg)thrice a day for 21 days.
Intervention2: Guduchidantyadi Malahar: Group 2
Dose-3gm thrice a day as local application for 21 days.
Cont
Sponsors
State Ayurvedic College and Hospital lucknow
Eligibility
Inclusion criteria
Inclusion criteria: Patients willing to participate in trial Adult Female who are in age group of 18-45 years Only married patient Patients having pruritus vulvae as a cardinal symptom with or without vaginal discharge
Exclusion criteria
Exclusion criteria: Patients below 18 years and above 45 years Patients unwilling too participate in the trial Patients after menopause. Patients who are willing to conceive. Patients of uterine prolapse and Ca-cervix. Patients on oral contraceptives or using intra uterine contraceptive device. Patients with diabetes mellitus, tuberculosis, severe hypertension, jaundice. Patients with chronic cervicitis, fibroid and malignancy. VDRL, HIV, HBsAg positive patient.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the efficacy of oral administration of Guduchidantyadi Vati and Guduchidantyadi Malahar in Pruritus vulvae Timepoint: Trial will be conducted for 1 month ( 21 days with medicine and 7 days without medicine) .Patient will be followed once a week during treatment and 7 days after the treatment is completed. | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the efficacy of trial drug on subjective parameters white discharge p/v, malodor, vulvar pain , coital frequency , dyspareunia , burning micturition & inflammation in vulvaTimepoint: 1 month | — |
Countries
India
Contacts
Public ContactDr Ekta Dubey
State Ayurvedic College and Hospital Lucknow
Outcome results
None listed